SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-186748
Filing Date
2022-07-01
Accepted
2022-07-01 08:30:07
Documents
17
Period of Report
2022-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d358140d8k.htm   iXBRL 8-K 33245
2 EX-1.1 d358140dex11.htm EX-1.1 170402
3 EX-5.1 d358140dex51.htm EX-5.1 7193
4 EX-99.1 d358140dex991.htm EX-99.1 8154
5 EX-99.2 d358140dex992.htm EX-99.2 8241
9 GRAPHIC g358140g0630082550771.jpg GRAPHIC 2534
  Complete submission text file 0001193125-22-186748.txt   415864

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20220629.xsd EX-101.SCH 2856
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20220629_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20220629_pre.xml EX-101.PRE 11707
11 EXTRACTED XBRL INSTANCE DOCUMENT d358140d8k_htm.xml XML 3448
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 221059694
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences